M R Jadus

Summary

Country: USA

Publications

  1. ncbi Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway
    M R Jadus
    Department of Laboratory Service, Veterans Affairs Medical Center, Long Beach, CA 90822, USA
    J Immunol 160:361-8. 1998
  2. ncbi Macrophages that kill glioma cells expressing the membrane form of macrophage colony stimulating factor are resistant to prostaglandin E2 and interleukin-10
    N S Zeineddine
    Department of Laboratory Service, Veterans Affairs Medical Center, Long Beach, CA 90822, USA
    Immunol Lett 70:63-8. 1999
  3. ncbi Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer
    C C Williams
    Department of Laboratory Service, Box 113, Veterans Affairs Medical Center, 5901 East 7th Street, Long Beach, California 90822, USA
    Mol Ther 3:216-24. 2001
  4. ncbi Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor
    Q Dan
    Diagnostic and Molecular Medicine Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA
    Int Immunopharmacol 1:737-48. 2001
  5. ncbi Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor
    Q Dan
    Diagnostic and Molecular Medicine Health Care Group, Veterans Affairs Medical Center, University of California, 5901 E. 7th Street, Long Beach, CA 90822, USA
    Mol Ther 4:427-37. 2001
  6. ncbi Gene expression and gene therapy in experimental duodenal ulceration
    S Szabo
    Path and Lab Med Service, VA Medical Center, 5901 E 7th Street, Long Beach, CA 90822 5201, USA
    J Physiol Paris 95:325-35. 2001

Collaborators

  • C A Lowell
  • Y Chen
  • Y Liu
  • S Kim
  • M Yoshida
  • Q Dan
  • C C Williams
  • H T Wepsic
  • E W Jeffes
  • H Trinh
  • R Sanchez
  • S Szabo
  • C Delgado
  • N S Zeineddine
  • T R Morgan
  • T Khomenko
  • C Lloyd
  • X Deng
  • H Matsumoto
  • Z Gombos
  • B Sippel
  • T V Tran
  • K Morgan
  • Z Sandor
  • M D Avina

Detail Information

Publications6

  1. ncbi Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway
    M R Jadus
    Department of Laboratory Service, Veterans Affairs Medical Center, Long Beach, CA 90822, USA
    J Immunol 160:361-8. 1998
    ..Using annexin V and acridine orange staining techniques, macrophages phagocytosized living mM-CSF-transfected tumor cells...
  2. ncbi Macrophages that kill glioma cells expressing the membrane form of macrophage colony stimulating factor are resistant to prostaglandin E2 and interleukin-10
    N S Zeineddine
    Department of Laboratory Service, Veterans Affairs Medical Center, Long Beach, CA 90822, USA
    Immunol Lett 70:63-8. 1999
    ..Thus, the mM-CSF may be an ideal agent to treat tumors that utilize either of these two immunosuppressive defense mechanisms that may block other forms of treatment...
  3. ncbi Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer
    C C Williams
    Department of Laboratory Service, Box 113, Veterans Affairs Medical Center, 5901 East 7th Street, Long Beach, California 90822, USA
    Mol Ther 3:216-24. 2001
    ..These observations suggest that breast cancer-specific immunity was induced by the inoculation of mM-CSF-expressing MADB106 tumor cells...
  4. ncbi Dexamethasone increases the expression of membrane macrophage colony stimulating factor from retrovirally transduced tumor cells expressing macrophage colony stimulating factor
    Q Dan
    Diagnostic and Molecular Medicine Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA
    Int Immunopharmacol 1:737-48. 2001
    ..This work suggests the possibility that dexamethasone may prove useful for vaccination purposes using mM-CSF retrovirally transfected tumor cells...
  5. ncbi Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor
    Q Dan
    Diagnostic and Molecular Medicine Health Care Group, Veterans Affairs Medical Center, University of California, 5901 E. 7th Street, Long Beach, CA 90822, USA
    Mol Ther 4:427-37. 2001
    ..Our work suggests that mM-CSF transduced hepatoma cells could be used as a tumor vaccine to stimulate immune responses against hepatocellular carcinoma...
  6. ncbi Gene expression and gene therapy in experimental duodenal ulceration
    S Szabo
    Path and Lab Med Service, VA Medical Center, 5901 E 7th Street, Long Beach, CA 90822 5201, USA
    J Physiol Paris 95:325-35. 2001
    ..Thus, gene expression studies provide new insights into the molecular mechanisms of duodenal ulceration and VEGF or PDGF gene therapy seems to be a new option to achieve a rapid ulcer healing...